We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Malaria Biomarkers Detected In Human Breath

By LabMedica International staff writers
Posted on 13 Apr 2015
The majority of diagnoses of malaria rely on a combination of clinical presentation and visualizing parasites in a stained blood film or by performing a rapid diagnostic test.

Human breath offers an attractive alternative to blood as the basis for simple, non-invasive diagnosis of infectious disease, and when breath samples were taken during controlled human malaria infection specific malaria associated volatiles could be detected in human breath.

Scientists at the Commonwealth Scientific and Industrial Research Organization (CSIRO) (Dickson, Australia) and their colleagues collected breath samples from volunteers that had been infected with the malaria parasite Plasmodium falciparum, who were enrolled in a drug trial. More...
The volunteers breathed through a cardboard tube into a chamber connected to a connected to a 3‐L impermeable aluminum gas bag (Shanghai Sunrise Instrument Co.; Shanghai, China).

Exhaled breath analysis was carried out by gas chromatography-mass spectrometry. The gas chromatograph 451 Model GC (Bruker Daltonik Inc.; Billerica, MA, USA) was used and the Bruker Daltonik Scion SQ single quadrupole mass was set with a full scan detection. Real-time polymerase chain reactions and cell cultures were also performed.

The team identified nine compounds whose concentrations varied significantly over the course of malaria infection: carbon dioxide, isoprene, acetone, benzene, cyclohexanone and four thioethers. The latter group: allyl methyl sulfide, 1-methylthio-propane, (Z)-1-methylthio-1-propene and (E)-1-methylthio-1-propene had not previously been associated with any disease condition.

Before antimalarial-drug treatment, there was evidence of concurrent 48 hour-cyclical changes in both the levels of thioethers and parasitemia. Phase-shifting the values for thioether concentrations by 24 hours, revealed a direct correlation between the parasitemia and volatile levels. Volatile levels declined monotonically at around 6.5 hours after initial drug treatment, correlating with clearance of parasitemia. The study was published online on March 25, 2015, in the Journal of Infectious Diseases.

Related Links:
Commonwealth Scientific and Industrial Research Organization
Shanghai Sunrise Instrument Co.
Bruker Daltonik Inc.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.